文献速递浆细胞疾病

A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo.

PubMed 文献 · Leukemia · 2017-07-28

This corrects the article DOI: 10.1038/leu.2016.388.

原文

This corrects the article DOI: 10.1038/leu.2016.388.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hipp S, Tai YT, Blanset D, et al. A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo. Leukemia. 2017. PMID: 28751764. doi:10.1038/leu.2017.219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。